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Summary
Objective: The mechanisms leading to degeneration of articular cartilage in osteoarthritis (OA) are complex and not yet fully understood.
Cathepsin K (CK) is a cysteine protease which can also cleave the triple helix of type II collagen. This exposes a neoepitope that can
now be identiﬁed by speciﬁc antibodies. The aim of this study was to obtain evidence suggesting a role for CK in naturally occurring equine
OA in both lesional and peri-lesional regions.
Methods: Articular cartilages (n¼ 12 horses; 5 healthy, 7 OA) were harvested from animals postmortem. A gross macroscopic examination,
histologic (Safranin O-Fast Green and Picrosirius red staining) and immunohistochemical evaluation were performed. Samples were divided
into normal appearing cartilage, peri-lesional and lesional cartilage. Cartilage degradation in the samples was graded histologically and
immunohistochemically. CK and possible CK cleavage were detected immunohistochemically with speciﬁc anti-protein and anti-neoepitope
antibodies, respectively. A comparison of CK neoepitope (C2K) production with the collagenase-generated neoepitope produced by matrix
metalloproteinases (MMP)-1, 8 and 13 (C2C) was also assessed immunohistochemically.
Results: CK and CK cleavage were signiﬁcantly more abundant in OA cartilage (both peri-lesional and lesional) when compared to remote
cartilage within the sample joint or cartilage from healthy joints. The immunohistochemical pattern observed for CK degradation (C2K) was
similar to that of collagenase degradation (C2C). Macroscopic cartilage changes and histologic ﬁndings were signiﬁcantly correlated with
immunohistochemistry results.
Conclusion: The data generated suggests that CK may be involved in cartilage collagen degradation in naturally occurring osteoarthritis.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The progressive degeneration of articular cartilage is
a hallmark feature in the pathogenesis of osteoarthritis
(OA), and leads to a loss of joint function and to debilitating
pain1. The molecular mechanisms that lead to degeneration
of the extracellular matrix of articular cartilage are complex
and a number of enzymes and their interrelated pathways
have been studied extensively2. However, the molecular
characterization of OA remains incomplete.
The principal molecules of the extracellular matrix of
articular cartilage are type II collagen and the proteoglycan
aggrecan, together comprising 95% of its dry matter3. Type
II collagen, a major structural component of the extracellular
matrix, is composed of three identical a-helical chains
arranged in a triple helical structure4. The triple helix is
cleaved by collagenases (MMPs) or matrix metalloprotei-
nases at a speciﬁc site to produce 3/4 and 1/4 fragments.1This study was funded by the Canadian Arthritis Network.
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375MMP-1, 8, 13 and 14 are all capable of this cleavage but
MMP-13 is currently believed to be the key player in type
II collagen degradation in OA5. These MMPs have been
the focus of most of the protease-related studies of type II
collagen cleavage in OA research in recent years6.
Cathepsin K (CK), a cysteine protease, is synthesized by
healthy and OA chondrocytes. It is now believed that this
enzyme could play an important role in the breakdown of
the cartilage collagen network in OA7. Evidence from
a study of the effects of an anti-inﬂammatory drug in an
experimental model of OA also suggests an important role
for CK in addition to the well-established role of MMPs, in
cartilage degradation8. CK, like MMP collagenases, is
capable of cleavage of the type II collagen triple helix. It
subsequently cleaves at multiple sites within the triple
helical region of both type I and II collagens. The primary
speciﬁc cleavage site close to the N-terminus of its triple he-
lix has been identiﬁed9,10 and a polyclonal antibody was
raised against the C-terminus of this neoepitope termed
C2K7. The latter authors also showed that this neoepitope
cannot be generated by collagenases and that CK cannot
generate the collagenase neoepitope.
Recent data has shown that CK is expressed in OA
cartilage11. Transgenic Del1 mice models of OA exhibit
up-regulation of CK expression in OA cartilage12. This
Fig. 1. Representative OA lesion on the distal metacarpus illustrat-
376 T. Vinardell et al.: Evidence to suggest that cathepsin K degrades articular cartilageanimal model harbours six additional copies of the 39 kb
murine gene for type II collagen (Col2al ) carrying a short
deletion mutation removing exon 7 and intron 7. This results
in production of shortened proa1 (II) collagen chains inca-
pable of ﬁbril formation in vivo and consequently a greatly
reduced collagen network in the cartilaginous extracellular
matrix. Upon ageing the Del1 mice develop early-onset
OA. The investigators observed CK in articular chondro-
cytes near sites of cartilage matrix destruction in the OA
mice12.
CK is now a target for disease modifying OA drugs
(DMOADS). We hypothesized that if CK is involved in car-
tilage degeneration then its expression and involvement in
matrix degradation would correlate with the severity of car-
tilage degradation in naturally occurring OA, which would
provide further evidence for its role in this disease.
Our objectives were to study CK expression and cleav-
age of type II collagen in healthy and naturally occurring
equine OA cartilage, and compare this with type II collagen
cleavage mediated by collagenases.ing 3 sites from which cartilage was harvested postmortem:
L¼ lesion, PL¼ adjacent to the lesion, and R¼ remote from the
lesion.
Materials and methodsCARTILAGE SPECIMENSArticular cartilage was aseptically harvested from the metacarpophalan-
geal joints (MCP) of 10 horses either euthanized for reasons unrelated to
joint disease at the Veterinary Teaching Hospital, University of Montreal (2
horses with clinical signs compatible with OA) or from a local abattoir (8
horses). The age and sex was recorded in the medical record or the age
of the animals was assessed by teeth examination13. The joints were
visually assessed, palpated and abnormalities noted. In addition to the
animals from the abattoir and clinic, material was harvested from 2 patients
with OA diagnosed on a clinical examination (carpi and interphalangeal
joint).SPECIMEN COLLECTIONTable IIThe joints were opened and imaged with high-resolution digital photogra-
phy (digital D1 Nikon camera, Tokyo, Japan) to document the macroscopic
distribution of cartilage lesions. The lesions were also manually mapped
and the joints were assessed for lesion extent with an assigned numeric
score for severity, based on visual assessment (Table I). A joint was consid-
ered an OA joint for the purposes of this study with a score  1. Macroscopic
signs of OA including synovitis and osteophytosis were semi-quantitatively
assessed (presence or absence) and recorded for each joint.
Full depth articular cartilage (to the calciﬁed zone) was removed with
a scalpel from the articular surfaces, within 5 h of death. A schematic draw-
ing was made of the areas from which the cartilage was removed. Cartilage
was harvested from the lesion (L), the area surrounding the lesion (peri-
lesion, PL), and an area remote from the lesion, corresponding to an area
of healthy appearing cartilage (remote, R) (Fig. 1). Cartilage was also har-
vested from corresponding areas of macroscopically healthy (lesion-free)
joints.Modified Mankin grade (SOFG)
Structure
Normal 0PREPARATION OF SECTIONSSurface irregularities 1
Fibrillation or clefts 2
Erosion up to 1/3 of cartilage thickness 3
Erosion up to 2/3 of cartilage thickness 4
Erosion> 2/3 of cartilage thickness
(Including complete ulceration)
5
CellsCartilage was embedded in optimal cutting temperature compound (OCT)
(Tissue Tek, Sakura Finetek USA, Inc. Torrance, CA, USA) and stored at
80 C until analysis. Full depth cartilage sections of 5 mm thickness were
cut with a cryostat (Leica CM 3050S). The cartilage sections were placed
on slides coated with silane (Scientiﬁc Device Laboratory, Des plaines, IL,
USA) which provided optimal adhesive qualities for performing immunohisto-
chemical staining techniques. Samples from healthy cartilage were placed
singly on each slide. When samples came from OA joints, the lesion, peri-Table I
Macroscopic grade
Normal 0
Fibrillation 1
Erosion 2
Ulceration 3lesion and remote specimens were all placed on the same slide allowing
a direct comparison of stain uptake between sites, within the same joints.HISTOLOGIC GRADINGThe sections were stained with Safranin O-Fast Green (SOFG), which
stains glycosaminoglycans (GAGs), and graded semi-quantitatively for de-
generative changes with a modiﬁed Mankin grade14 (Table II). Following
grading, the joint compartment with evidence of most severe histological dis-
ease was selected for subsequent study and analysis. Sections were se-
lected from the sites with the most severe lesions in the joints with OA
conﬁrmed on macroscopic examination.
Picrosirius red was employed to stain type II collagen in the samples.
Brieﬂy, it enhances collagen birefringence, and thus reveals the orientation
of the collagen ﬁbers in the various zones of the cartilage. Packing of colla-
gen molecules and ﬁber thickness determine the polarization colours of Pic-
rosirius red stained collagens; thin ﬁbers are green to yellowish-green and
thicker ﬁbers are yellowish-orange to red15. All frozen sections were stained
as described previously16. The Picrosirius red stained sections were graded
semi-quantitatively for degenerative changes employing polarized light mi-
croscopy to assess collagen structure (Table III). A loss of integrity repre-
sented a loss of the normal architecture of the samples when compared to
the normal articular cartilage. The cartilage sections were examined with
a Leica DM4000B polarized light microscope (PLM) equipped with interfer-
ence ﬁlters and compensator plates mounted with a Leica DFC320 video
camera.Normal 0
Clusters 1
Hypocellularity 2
Safranin O staining
Normal 0
Slight reduction 1
Moderate reduction 2
Severe reduction 3
Table III
Collagen structural grade (Picrosirius Red)
Normal 0
Loss of integrity of 1/3 of cartilage thickness 1
Loss of integrity of 2/3 of cartilage thickness 2
Loss of integrity of 3/3 of cartilage thickness 3
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C2K generated cleavage neoepitope in type II collagen. There is sequence
identity between equine and human type II collagens17 at the primary site
where the CK cleaves type II collagen9 generating the GEAGKPG C-terminal
neoepitope (termed C2K) which is recognized by a rabbit polyclonal anti-
body7. Serum with a titer of 1:1 106 was employed in this study.
CK antiserum. As described previously for rat CK18, a rabbit antiserum was
prepared against a peptide-ovalbumin conjugate representing the C-terminal
dodecapeptide-of human CK19.
C2C mouse monoclonal antibody to collagenase-generated cleavage neo-
epitope in type II collagen. This neoepitope resides at the C-terminus of this
primary collagenase cleavage site20. The antibody was generated in ascitic
ﬂuid in mice and puriﬁed by protein A-afﬁnity chromatography21. The neoe-
pitope is recognized by this antibody in multiple species including the
horse22e25.IMMUNOLOCALIZATIONThe methods used in this study, were adapted from those used by
Hollander et al26. Brieﬂy, frozen sections (5 mm) were ﬁxed in 4% paraformal-
dehyde. After rinsing with phosphate buffered saline (PBS), sections were
then treated with chondroitinase ABC in a humidiﬁed environment to
enhance permeability of the extracellular matrix by removal of chondro€ıtin
sulphate. The sections were incubated with 0.2 M EDTA to ensure removal
of calciﬁc deposits which otherwise non-speciﬁcally bind immunoglobulins.
Localization by immunoperoxidase staining involved the use primary
antisera or ascitic ﬂuid each diluted in PBS (1/100) containing 1% wt/vol
BSA (50 ml per section). The secondary antibodies employed in these
studies were biotin-labelled polyclonal swine anti-rabbit antibody (concentra-
tion 1 g/L) for C2K and CK and a biotin-labelled polyclonal rabbit anti-mouse
(concentration 0.79 g/L) in the case of C2C (Dakocytomation, Denmark).
The secondary antibodies were diluted in PBS (1/700) containing 1% wt/vol
BSA and secondary antibody binding was detected with streptavidin-
peroxidase. The peroxidase reaction was developed and the product
enhanced with copper-H2O2/silver intensiﬁcation as previously described
27.
Preabsorption of the primary antibody (C2K) with the immunizing peptide
was performed to eliminate staining (negative controls) for each batch
(Fig. 2) negative control of a test slide without primary antibody (buffer and
all other reagents added) was also included for each batch (CK and C2C).
Semi-quantitative assessment of the immunohistochemical staining was per-
formed using a modiﬁed scale adapted from Hollander et al26 (Table IV).IMMUNOHISTOMORPHOMETRIC ANALYSISThe amount of CK was assessed semi-quantitatively by determining the
number (percentage) of chondrocytes or lacunae that stained positive
(Fig. 6). Each section was observed with a light microscope (400; Labphot
SA, Nikon, Japan) and divided into three macroscopic ﬁelds. All chondro-
cytes/lacunae were counted in each ﬁeld. The results of three ﬁelds were
averaged for each section. The total number of cells/lacunae that stained
positive for CK was determined. The results were expressed as the percent-
age of cells that stained positive for CK (cell/lacuna score).
All slides were evaluated by two different observers, independently.STATISTICAL ANALYSISFor paired comparisons in the same horses, between the remote, peri-le-
sion and lesion grades, a Wilcoxon signed rank test was employed. Differ-
ences between healthy and OA joints (remote, peri-lesion and lesion) from
different animals were assesed by the Wilcoxon rank sum test.
Correlations between data groups were examined by employing a Spear-
man rank order correlation. A level of P< 0.05 was considered signiﬁcant. All
calculations were performed using commercially available software (NCSS
2004, Kaysville, UT, USA).ResultsANIMALSSpecimens were collected from an abattoir or from the
Veterinary Teaching Hospital of the University of Montreal
(5 healthy horses and 3 showing clinical signs of OA).
These specimens originated from 4 females, 1 male and
5 geldings with a mean  SD age of 8.8 6.5 years.
Horses from the teaching hospital were euthanatized for
reasons unrelated to articular disease but presented clinical
signs of OA (joint distension and mild lameness) (2 horses).
In addition specimens (2 horses) were obtained with clini-
cally active OA conﬁrmed by an extensive examination at
the hospital. These included a 12 year old QH mare, do-
nated for euthanasia for research purposes to the hospital
because of debilitating pain related to severe OA in both
carpi. Clinical examination and radiographs conﬁrmed the
diagnosis and following euthanasia, cartilage was har-
vested from the affected joints. A 7 year old crossbred geld-
ing, used for barrel competition was presented for chronic
forelimb lameness caused by proximal interphalangeal
OA. On clinical examination the horse was lame (grade 4/5)
and the diagnosis of OA was conﬁrmed on radiographic
evaluation. Cartilage was collected during a surgical
arthrodesis to alleviate pain and restore function.MACROSCOPIC FINDINGSHealthy articular cartilage was opaque with a glistening
smooth surface. In healthy joints, the macroscopic grade
of the cartilage was 0. No synovitis or osteophytes were
observed.
In OA joints synovitis was observed in 4 out of 7 horses
and osteophytes in 5 out of 7. Macroscopic cartilage grade
ranged from 1 to 3; articular cartilage ﬁbrillation, erosion and
ulceration were observed (Fig. 1).HISTOLOGIC EXAMINATIONSafranin O-Fast Green
Histologic appearance of the articular cartilage from
healthy joints was consistent with healthy hyaline cartilage
with an homogeneous uptake of the SOFG stain. In con-
trast, reduction of the staining, hypocellularity and ulcera-
tion was observed in the most severe OA cartilage
sections (Fig. 4). Following observation of all SOFG speci-
mens from the metacarpal bone, the carpus and the ﬁrst
phalanx (medial and lateral for each bone), we selected
for study in all subsequent analysis sections from the com-
partment with the greatest degeneration (highest modiﬁed
Mankin grade), which provided a wide landscape of lesions.
The modiﬁed Mankin grade ranged between 0 and 3 in car-
tilage sections from healthy joints, where grade 3 corre-
sponded to a slight reduction of staining in the very
superﬁcial zone of the cartilage (Fig. 4). In the OA joints
the histologic Mankin grade ranged from 0 to 5 at remote
sites, 2 to 7 in the peri-lesion area and from 3 to 10 in the
lesion sample (Fig. 5). There was a statistically signiﬁcance
difference in histological grades between healthy speci-
mens and peri-lesion and lesion sections of cartilage from
OA joints (P< 0.05). Furthermore, in OA joint specimens,
the histological grade was signiﬁcantly higher in the carti-
lage lesion and peri-lesion when compared to the remote
site. The histological grade was also signiﬁcantly higher in
the lesion compared with the peri-lesion (P< 0.05) (Fig. 5).
Fig. 2. C2K immunohistochemically stained sections with corresponding controls of articular cartilage from 3 sites within OA joints (remote (R),
peri-lesion (PL) and lesion (L)). Preabsorption of the primary antibody with the immunizing peptide was performed on the control sections.
A marked increase in stain is observed in the R, PL & L sites when compared to controls (original magniﬁcation 50, bar¼ 100 mm).
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Healthy sections had a predominance of aligned collagen
ﬁbers and homogeneous staining in comparison to OA
cartilage. A loss of collagen structure with the presence of
non-aligned ﬁbers and heterogeneous staining progressed
from the surface to the deeper zones of cartilage in OA
specimens (Fig. 4). The pattern of staining also changed
with the progression of the disease; in remote sites there
was a homogenous pattern and ﬁbers appeared densely
packed with progressive degeneration of the ordered struc-
ture revealing individual collagen ﬁbrils. In the healthy and
peri-lesion samples, ﬁbril colour was orange, red and yel-
low, but with increased severity of the disease, we observed
thinning of the ﬁbrils with the colours changing to green or
blue (Fig. 4).
ThePicrosirius redgradewas0 inbothhealthy joint sections
and in remote regions in OA joints. Grade 1 alone was attrib-
uted to peri-lesion sections and the grade ranged from 1 to 3
in OA lesions. The differences in grades between healthy
and OA cartilage sections (lesion and peri-lesion) wereTable IV
Immunohistochemical grade
No staining 0
Satining in the superﬁcial layer 1
Superﬁcial and midzone staining 2
Deep zone staining 3
Staining of most of the extracellular matrix throughout
the depth of the cartilage, combined with a loss of
staining in the superﬁcial zone associated with ﬁbrillation
4statistically signiﬁcant, and there was a signiﬁcantly increased
grade between the lesion vs remote and peri-lesion and peri-
lesion vs remote sections in OA joints (P< 0.05) (Fig. 5).IMMUNOLOCALIZATIONC2K: Cleavage of type II collagen by CK
Healthy cartilage showed minimal immunostaining in the
very superﬁcial zone. An increase in stain occurred in sec-
tions from OA joints and with advanced disease (Fig. 3) and
corresponded to the loss of SOFG staining. Overall, there
was more staining, which was diffused and localized in
the matrix, in the most superﬁcial cartilage where evidence
of ﬁbrillation or erosion was observed. The depth of the
staining increased with the severity of OA. In the most
severe cases (n¼ 2) we observed staining of most of the
extracellular matrix throughout the depth of the cartilage,
combined with a loss of staining in the superﬁcial zone as-
sociated with ﬁbrillation (Fig. 3). The immunohistochemical
grades of sections from healthy joints and in remote carti-
lage sections in OA joints ranged from 0 to 1. This in-
creased to 2 in the peri-lesion area and from 2 to 4 in
lesions. There was no statistically signiﬁcant difference be-
tween immunostaining of sections from healthy joints and
remote cartilage from OA joints but there was a statistically
signiﬁcant increase in stain in lesion and peri-lesion sec-
tions from OA joints when compared to remote cartilage
from the same joint and to cartilage from healthy joints
(P< 0.05). Finally the grade was signiﬁcantly higher in the
lesion compared to the peri-lesion sites (P< 0.05) (Fig. 5).
Fig. 3. Immunohistochemically stained representative sections of articular cartilage from 3 sites within OA joints (remote (R), peri-lesion (PL)
and lesion (L)). For C2K immunolocalization (CK collagen cleavage) and C2C immunolocalization (MMPs collagen cleavage) we observed an
increase in stain in OA sections and the depth of the staining increased with the severity of OA. CK immunolocalization was situated in chon-
drocyte lacunae and surrounding matrix. Brown colour represents positive staining (original magniﬁcation 50, bar¼ 100 mm).
Fig. 4. Representative cartilage histologic sections from 3 sites in OA joints: remote (R), peri-lesion (PL) and lesion (L). A, Safranin O-Fast
Green (SOFG) (stains proteoglycan) stained sections showed a reduction of the staining, hypocellularity and loss of cartilage thickness
with the progression of OA. B, Picrosirius red staining (stains collagen) illustrated non-aligned ﬁbers and heterogeneous staining with the pro-
gression of the disease from the surface to the deeper zones of cartilage (original magniﬁcation 50, bar¼ 100 mm).
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Fig. 5. Vertical scatter plot illustrating comparisons between the histological and immunohistochemical assessments of cartilage sections from
healthy (H) and OA joints: remote cartilage (R), peri-lesion (PL) and in the lesion (L). Horizontal bar indicates mean score.* P< 0.05 vs N;
x P< 0.05 vs R; { P< 0.05 vs PL.
380 T. Vinardell et al.: Evidence to suggest that cathepsin K degrades articular cartilageCK
Minimal immunostaining was visible in cartilage from
healthy joints. In contrast strong staining was observed in
lesion and peri-lesion sites from OA joints which corre-
sponded to the loss of SOFG stain in the same sections
of cartilage. The staining pattern was different to that ob-
served with C2K. CK staining was predominantly situated
in chondrocytes in early stages of the disease; the increase
and depth of the staining was focal and remained within the
chondrocytes in the early stages of the disease. In the ad-
vanced stages in all the lesion sections hypocellularity
and erosion were present and staining of the extracellular
matrix was also observed. Overall the staining tended to
be peri-cellular surrounding the lacunae (Figs. 3 and 6).
The percentage of chondrocytes/lacuna stained from
healthy joints sections was 20%, except for one case
where it was 54%. In the remote sections from OA joints
the staining pattern was similar to that observed in healthy
cartilage. In specimens from healthy joints, peri-lesion and
lesion sites percentage cell staining varied between 40%
and 100%. The CK staining was signiﬁcantly higher in
peri-lesion and lesion sections from OA joints when com-
pared to healthy joint sections and remote sections of the
same joints (P< 0.05) (Fig. 5). The percentage of stained
cells/lacunae was also signiﬁcantly higher in the lesion
compared to peri-lesion (P< 0.05) (Fig. 5).C2C: Cleavage of type II collagen by collagenases
The pattern of staining observed in healthy cartilage was
similar to that observed for C2K. In the OA cartilage sections
the depth of the staining increased with the severity of OA. In
contrast to C2K, we did not observe grade 4 (corresponds to
staining of most of the extracellular matrix throughout the
depth of the cartilage, combined with a loss of staining in
the superﬁcial zone associated with ﬁbrillation) in any of the
sections (Fig. 3). The immunohistochemical grade of carti-
lage from healthy joints and of remote cartilage of OA joints
ranged from 0 to 1. At peri-lesion sites the grade ranged
from 0 to 2 and from 1 to 3 in the lesion (Table IV). The C2C
immunostaining grade was signiﬁcantly higher in the lesion
when compared to the other sites within the OA joint and
with healthy sections (P< 0.05) (Fig. 5).
Omission of primary antibody from the immunohisto-
chemical procedure (C2K, C2C and CK) resulted in loss
of immunostaining in all cases.CORRELATIONSThe signiﬁcant Spearman correlations between the vari-
ous parameters assessed are shown in Table V. C2K
strongly correlated with the macroscopic grade, histologic
grade and immunohistochemical grade for CK and C2C.
Table V
Spearman Rank correlations
C2K r P
Macro 0.84 0.0005
SOFG 0.83 0.0006
Picrosirius Red 0.78 0.002
C2C 0.73 0.006
Cathepsin K 0.82 0.0009
C2C
Macro 0.76 0.003
SOFG 0.82 0.001
Picrosirius Red 0.72 0.008
Cathepsin K
Macro 0.85 0.0004
SOFG 0.81 0.001
Picrosirius Red 0.77 0.003
C2C 0.83 0.0007
Picrosirius Red
Macro 0.93 0.00001
SOFG 0.79 0.001
SOFG
Macro 0.76 0.003
Spearman rank correlations between immunohistochemical
grades, macroscopic joint grades and histologic grades. Macro:
Macroscopic grade. SOFG: Modiﬁed Mankin grade. C2K: immuno-
histochemical grade for type II collagen cleavage by Cathepsin K.
C2C: immunohistochemical grade for type II collagen cleavage by
collagenases (MMP). Cathepsin K: immunohistochemical grade
for cathepsin K localization.
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381Osteoarthritis and Cartilage Vol. 17, No. 3CK staining also strongly correlated with the macroscopic
and histologic grade (P< 0.05).Discussion
In this study we provide evidence that CK cleavage of
type II collagen occurs in OA cartilage and that it correlates
with other histopathological indicators of cartilage degrada-
tion severity. Moreover, the CK generated cleavage neoepi-
tope in type II collagen, which is not produced by
collagenases7, is also signiﬁcantly increased and this
correlated with the presence of CK and with the severity
of cartilage degeneration. Furthermore, the pattern of deg-
radation observed with CK was similar to and correlated
with that observed with collagenases and the loss of picro-
sirius red staining. Together these results suggest that CK
degradation may, like collagenases, play an important role
in cartilage matrix destruction and in progression of OA.
We studied equine articular cartilage from animals with
naturally occurring OA, which serves as a model for human
disease. CK has been previously identiﬁed in cartilage in
animal models of OA by others2,12, but only some reports
had identiﬁed the enzyme28 and its products of degradation
in naturally occurring OA7.
The spectrum of lesions available for study within the OA
joints, including lesion, peri-lesion and remote cartilage with
a normal macroscopic appearance provided a landscape of
cartilage matrix changes corresponding to both the early
and later advanced lesions of OA. The model of OA em-
ployed herein mimics the human studies previously carried
out by Squires et al29 in which they provided the ﬁrst molec-
ular evidence to suggest that the development of OA
involves the formation and spread of focal lesions of OA.
They also provided evidence that increased collagenase
activity was an important component of this process.
382 T. Vinardell et al.: Evidence to suggest that cathepsin K degrades articular cartilageCartilage samples were harvested in the lesion, adjacent
to and remote from the lesion and they exhibited a gradient
of histologic change, molecular damage and altered synthe-
sis from healthy cartilage to the lesion. We found a similar
correlation with both histologic and immunostaining tech-
niques but this time studying CK degradation. Squires et
al observed a decrease in type II collagen content and an
increase in collagenase activity in the cartilage harvested
from areas adjacent to the lesion. Picrosirius red staining
in the present study revealed a disorganization of the colla-
gen structure and thinning of the type II collagen ﬁbrils in the
peri-lesion site. Similarly on SOFG sections hypocellularity,
progressive loss of proteoglycans from the superﬁcial zone
to the deepest zone and cartilage ﬁbrillation were observed
with progressive severity of degradation, conﬁrming the dis-
ease status of the sections studied.
However, an increase in putative CK activity in the carti-
lage, assessed by the presence of the C2K neoepitope,
was observed in the very superﬁcial zone, in the remote
site and the pattern of staining increased with the degree
of disease, progressing deeper into the cartilage sections.
This pattern of surface degradation progressing deeper
into the tissues is similar to that observed by others26 and
would further support the hypothesis that cartilage degrada-
tion begins at the articular surface. It is interesting that the
immunohistochemical pattern we observed for CK degrada-
tion (C2K) in this study correlated with that due to collage-
nase degradation (C2C). We also observed in some
samples C2K staining of most of the extracellular matrix
through the depth of the cartilage, combined with a loss of
staining in the superﬁcial zone associated with ﬁbrillation
(grade 4). According to Hollander and collaborators grade
4 may represent severely damaged matrix in which the
collagen neoepitopes have been lost from damaged mole-
cules, at the articular surface.
The present work demonstrates a combination of activity
of both collagenases and CK in OA cartilage. CK has previ-
ously been shown to be active at both acid and neutral
pH28. However, MMPs are only active at neutral or even
slightly alkaline pH30. Kontinnen and collaborators have
shown that progression of the disorganization of the super-
ﬁcial articular hyaline cartilage in OA is associated with
progressively increasing Hþ concentrations. Furthermore,
they observed that CK extracted from normal appearing
articular hyaline cartilage which exhibited a neutral matrix
pH was in the latent, high molecular weight pro form,
whereas CK in OA cartilage, with low matrix pH, was in
the active, proteolytically processed, low molecular weight
form28. They postulated that as the pH falls, OA progresses
and while MMPs are decreasingly active, CK is increasingly
active. Combining our results with previous studies, we pos-
tulate that CK is active concurrently with MMPs, but when
the pH is acidic, MMP activity may decrease while CK con-
tinues to degrade cartilage in an acidic environment. This
could explain the similar patterns of staining we observed;
grade 4 was observed on C2K stained sections alone and
overall immunostaining grades were lower for the MMP
products of degradation (C2C) in our samples. From the
data observed CK cleavage could occur secondary to
MMP-cleavage, but additional studies are needed to eluci-
date the exact mechanism of CK activity in OA joints.
Results of previously published investigations illustrate
the ability of CK to degrade both type II collagen and aggre-
can in articular cartilage9,31. Recent evidence also has been
provided that the collagenolytic activity of CK in human car-
tilage is enhanced by GAGs, more speciﬁcally, chondroitin
and keratan sulphate molecules10. These GAGs are easilyliberated by CK activity from aggrecan aggregates or carti-
lage and can subsequently form complexes with CK32. The
complex exhibits potent triple helical collagen degrading ac-
tivity, whereas monomeric CK has no collagenase activity,
they also increase the pH stability of the enzyme at neutral
pH. This means that collagen is accessible to degradation
by CK complexes at both neutral and acidic pH33.
It is important to point out that the pattern of CK immunos-
taining observed revealed some interesting insights into the
enzyme’s presence with disease progression. Staining was
ﬁrst observed in the cells in the remote sections in OA joints
but minimally in normal healthy joints and with progression
of the disease, peri-cellular staining around chondrocytes
became evident with a spread of the stain into the extracel-
lular matrix. This clearly indicated the chondrocytes as the
source of CK and furthermore that it is released from the
cells with progression of the disease. The present observa-
tions in naturally occurring osteoarthritis are in agreement
with those of Morko and coworkers, who observed the
same pattern of staining in an experimental mouse model
of OA11. They detected an increase in the number of CK
positive cells in articular cartilage, particularly in the vicinity
of articular defects in early OA lesions. The same pattern of
staining was observed in bovine articular cartilage explants
stimulated with TNF-a and oncostatin M. High immunoreac-
tivity of CK in the extracellular matrix was observed in
stimulated chondrocytes and without stimulation the en-
zyme was present intracellularly stored in the lysosomes34.
Overall, these complex observations provide new and
interesting insights for the potential role of CK in naturally oc-
curring OA. CK has been previously identiﬁed at the
osteochondral junction in early hypertrophic chondrocytes35
in healthy foetal or juvenile equine cartilage samples. It is
known that type X collagen expression is associated with hy-
pertrophic chondrocytes in normal cartilage but is also asso-
ciated with an altered phenotype in OA cartilage36. We
postulate that the expression of CK in OA cartilage may
also reﬂect an alteration in phenotype toward a more hyper-
trophic proﬁle, similar to that observed for type X collagen.
The results of this study provide additional evidence for
an important role of CK in cartilage degradation in naturally
occurring OA. Dejica and collaborators7 studied the involve-
ment of CK in human OA. They also studied CK products of
degradation and they observed C2K increased with age in
articular cartilage and that it was signiﬁcantly elevated in
OA cartilages compared to adult non-arthritic cartilages.
Also in cartilage explants from OA patients the generation
of the neoepitope was signiﬁcantly reduced in culture by
a very selective non-toxic inhibitor of CK.
Conversely, it is also possible that CK activity on type II col-
lagen inOAcartilage couldbebeneﬁcial, by removingbioactive
collagen II peptides/epitopes implicated in the pathogenesis
progressive cartilage breakdown in OA but this needs to be
investigated37.
The results presented here demonstrate that cartilage
matrix degeneration, the presence of CK in equine OA car-
tilage and type II collagen cleavage are closely correlated.
Consequently we postulate that CK has an important role
in cartilage degradation in naturally occurring OA in addition
to collagenases. All this data suggests that CK should be
considered as a possible target for drug development for
the inhibition of cartilage degradation in OA.
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